Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Raffaele Ratta
Personalized Therapy in Renal Cell Carcinoma: Are the Different Tyrosine Kinase Inhibitors the Same for Any Patient?
Expert Review of Precision Medicine and Drug Development
Molecular Medicine
Drug Discovery
Genetics
Pharmacology
Related publications
Personalized Therapy of Tyrosine Kinase Inhibitors
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Brain Metastases From Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors
Clinical Genitourinary Cancer
Oncology
Urology
Concomitant Oral Tyrosine Kinase Inhibitors and Bisphosphonates in Advanced Renal Cell Carcinoma With Bone Metastases
British Journal of Cancer
Cancer Research
Oncology
Do Tyrosine Kinase Inhibitors Lose Favor in Treatment of First-Line Metastatic Renal Cell Carcinoma?
Future Oncology
Medicine
Cancer Research
Oncology
Patient-Specific Molecular Alterations Are Associated With Metastatic Clear Cell Renal Cell Cancer Progressing Under Tyrosine Kinase Inhibitor Therapy
Oncotarget
Oncology
The Expression and Role of Tyrosine Kinase ETK/BMX in Renal Cell Carcinoma
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Future Perspectives for Personalized Immunotherapy in Renal Cell Carcinoma
Expert Opinion on Biological Therapy
Drug Discovery
Clinical Biochemistry
Pharmacology
Efficacy of Targeted Therapy for Metastatic Renal Cell Carcinoma in the Elderly Patient Population
Clinical Genitourinary Cancer
Oncology
Urology
How Sensitive Are Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors for Squamous Cell Carcinoma of the Lung Harboring EGFR Gene–Sensitive Mutations?
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
